Biotech Values

[DewDiligence]

Glatopa decision-making is not solely controlled by NVS; rather, NVS and MNTA have a joint development committee to oversee Glatopa in which NVS has responsibility for commercialization.

For instance, if NVS/MNTA were to seek approval of Glatopa in the EU, MNTA would be involved in the regulatory submissions to the EMA.